Psilocybin Therapy Offers "Paradigm-Changing Alternative" to Conventional Treatment for Depression, Clinical Trials Show
UNITED STATES, JUN 16 – Over half of cancer patients experienced sustained remission of depression symptoms two years after a single psilocybin dose combined with psychotherapy, indicating durable therapeutic effects.
- A single dose of psilocybin has been shown to provide lasting relief from depression and anxiety in cancer patients suffering from major depressive disorder, according to results from a clinical trial.
- Two years post-treatment, 53.6% of patients demonstrated significant depression reduction, with 50% achieving sustained remission.
- At the two-year follow-up, psilocybin reduced anxiety in 42.9% of patients.
- These findings suggest that psilocybin-assisted therapy may serve as a potent and safe alternative to conventional antidepressants for cancer patients' emotional challenges.
47 Articles
47 Articles
Can Ketamine Help Treat Depression?
In a new study, scientists watched something strange happen inside the brain after a single dose of ketamine: the usual cognitive chain of command seemed to collapse. Normally, sensory info comes in through lower-level brain networks, then gets filtered up to higher-level regions that run things like decision-making, introspection, and memory. But after ketamine, those boundaries got fuzzy. The brain’s high-level networks loosened control, and c…
Marijuana Moment
newsbudz.comHigh Doses Of LSD Lead To ‘Greater Reductions In Depression’ Compared To Low Doses Of The Psychedelic, New Study Finds
Taking a high dose of LSD, coupled with assisted therapy, led to “greater reductions in depression” among patients compared to those who received a low dose of the psychedelic, according to a new study. Researchers at the University of Basel in Switzerland investigated the therapeutic potential of LSD for people with moderate-to-severe major depressive disorder, and they found the substance showed “promise” as a “novel approach” to treating the …
Psychedelic Compound Psilocybin Can Benefit Cancer Patients with Depression
Researchers at the U.S. company Sunstone Therapies in Rockville, Maryland, have recently published new results from a Phase II clinical trial showing that a single dose of psilocybin, a natural psychedelic compound found in mushrooms, can greatly reduce symptoms of anxiety and depression in cancer patients with major depressive disorder. The findings of the study are published in the journal Cancer in a paper titled “Long-Term Benefits of Singl…
Coverage Details
Bias Distribution
- 59% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
